Stevanato Group S.p.A. revenue for the last year amounted to 1.14 B USD, the most of which — 1.01 B USD — came from its highest performing source at the moment, Biopharmaceutical and Diagnostic Solutions, the year earlier bringing 950.62 M USD. The greatest contribution to the revenue figure was made by EMEA — last year it brought Stevanato Group S.p.A. 722.35 M USD, and the year before that — 685.54 M USD.